Enhanced cancer cell killing by a targeting gold nanoconstruct with doxorubicin payload under X-ray irradiation

Hongyu Zhou, Yi Zhang, Gaoxing Su, Shumei Zhai, Bing Yan

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In this report, a cancer-targeting nanoconstruct enters a cancer cell four times more readily than non-targeting nanoparticles. Inside the cell, the nanoconstruct conducts a double DNA attack from a DNA intercalating drug doxorubicin and radiation-enhancing gold nanoparticles achieving 2.5 fold higher DNA double strand breakage in the cancer genome. An overall 4.0 or 2.7-fold increase in cancer cell killing was achieved compared to the free drug without or with X-ray irradiation and a significant reduction in nonspecific toxicity to folate receptor-negative cells demonstrated the unique advantage of a nanomedicine approach to future chemotherapy and radiotherapy.

Original languageEnglish (US)
Pages (from-to)21596-21603
Number of pages8
JournalRSC Advances
Volume3
Issue number44
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Gold
Doxorubicin
DNA
Cells
Irradiation
X rays
Nanoparticles
Medical nanotechnology
Chemotherapy
Radiotherapy
Folic Acid
Pharmaceutical Preparations
Toxicity
Genes
Radiation

ASJC Scopus subject areas

  • Chemistry(all)
  • Chemical Engineering(all)

Cite this

Enhanced cancer cell killing by a targeting gold nanoconstruct with doxorubicin payload under X-ray irradiation. / Zhou, Hongyu; Zhang, Yi; Su, Gaoxing; Zhai, Shumei; Yan, Bing.

In: RSC Advances, Vol. 3, No. 44, 01.01.2013, p. 21596-21603.

Research output: Contribution to journalArticle

Zhou, Hongyu ; Zhang, Yi ; Su, Gaoxing ; Zhai, Shumei ; Yan, Bing. / Enhanced cancer cell killing by a targeting gold nanoconstruct with doxorubicin payload under X-ray irradiation. In: RSC Advances. 2013 ; Vol. 3, No. 44. pp. 21596-21603.
@article{cb1e807460e44fcc88dcb91c1ae73f0d,
title = "Enhanced cancer cell killing by a targeting gold nanoconstruct with doxorubicin payload under X-ray irradiation",
abstract = "In this report, a cancer-targeting nanoconstruct enters a cancer cell four times more readily than non-targeting nanoparticles. Inside the cell, the nanoconstruct conducts a double DNA attack from a DNA intercalating drug doxorubicin and radiation-enhancing gold nanoparticles achieving 2.5 fold higher DNA double strand breakage in the cancer genome. An overall 4.0 or 2.7-fold increase in cancer cell killing was achieved compared to the free drug without or with X-ray irradiation and a significant reduction in nonspecific toxicity to folate receptor-negative cells demonstrated the unique advantage of a nanomedicine approach to future chemotherapy and radiotherapy.",
author = "Hongyu Zhou and Yi Zhang and Gaoxing Su and Shumei Zhai and Bing Yan",
year = "2013",
month = "1",
day = "1",
doi = "10.1039/c3ra43838d",
language = "English (US)",
volume = "3",
pages = "21596--21603",
journal = "RSC Advances",
issn = "2046-2069",
publisher = "Royal Society of Chemistry",
number = "44",

}

TY - JOUR

T1 - Enhanced cancer cell killing by a targeting gold nanoconstruct with doxorubicin payload under X-ray irradiation

AU - Zhou, Hongyu

AU - Zhang, Yi

AU - Su, Gaoxing

AU - Zhai, Shumei

AU - Yan, Bing

PY - 2013/1/1

Y1 - 2013/1/1

N2 - In this report, a cancer-targeting nanoconstruct enters a cancer cell four times more readily than non-targeting nanoparticles. Inside the cell, the nanoconstruct conducts a double DNA attack from a DNA intercalating drug doxorubicin and radiation-enhancing gold nanoparticles achieving 2.5 fold higher DNA double strand breakage in the cancer genome. An overall 4.0 or 2.7-fold increase in cancer cell killing was achieved compared to the free drug without or with X-ray irradiation and a significant reduction in nonspecific toxicity to folate receptor-negative cells demonstrated the unique advantage of a nanomedicine approach to future chemotherapy and radiotherapy.

AB - In this report, a cancer-targeting nanoconstruct enters a cancer cell four times more readily than non-targeting nanoparticles. Inside the cell, the nanoconstruct conducts a double DNA attack from a DNA intercalating drug doxorubicin and radiation-enhancing gold nanoparticles achieving 2.5 fold higher DNA double strand breakage in the cancer genome. An overall 4.0 or 2.7-fold increase in cancer cell killing was achieved compared to the free drug without or with X-ray irradiation and a significant reduction in nonspecific toxicity to folate receptor-negative cells demonstrated the unique advantage of a nanomedicine approach to future chemotherapy and radiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84886540339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886540339&partnerID=8YFLogxK

U2 - 10.1039/c3ra43838d

DO - 10.1039/c3ra43838d

M3 - Article

AN - SCOPUS:84886540339

VL - 3

SP - 21596

EP - 21603

JO - RSC Advances

JF - RSC Advances

SN - 2046-2069

IS - 44

ER -